Early stage biotech company focused on commercialization of dry-eye treatment, and orphan drug for systemic sclerosis.
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | Innova Mem... | innovamemp... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 10.07.2007 | ArGentis P... | ArGentis Pharmaceuticals, a Me... | - | - | venturebea... |